Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

XIjing Hospital of Air Force Military Medical University

1 abstract

Abstract
Tislelizumab (Tisle) combined with/without gemcitabine and cisplatin (GC) as adjuvant therapy in patients at high risk after upper urothelial carcinoma (UTUC) surgery: A real-world study.
Org: XIjing Hospital of Air Force Military Medical University, Xi’an, China, Xijing Hospital Fourth Military University, the Air Force Military Medical University, Xiijng Hospital,